Reference health

Efficient Gene Silencing in Brain Tumors with Hydrophobically Modified siRNAs

https://doi.org/10.1158/1535-7163.mct-17-1144
CiteStamped reference-health badge
32/32 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 32 checked references that resolve
resolves10.1038/nrneurol.2015.242
Progress in glioma diagnosis, classification and treatment
resolves10.1016/j.lfs.2017.08.027
RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials
resolves10.3322/caac.20069
Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
resolves10.1016/j.pharmthera.2015.05.005
Glioblastoma multiforme: Pathogenesis and treatment
resolves10.3389/fonc.2015.00251
Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence
resolves10.3389/fonc.2015.00159
Targeting Aggressive Cancer Stem Cells in Glioblastoma
resolves10.1101/gad.261982.115
Cancer stem cells in glioblastoma
resolves10.1038/nrd892
The druggable genome
resolves10.1038/nbt.3765
The chemical evolution of oligonucleotide therapies of clinical utility
resolves10.1073/pnas.1701911114
Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression
resolves10.1038/mtna.2015.38
Hydrophobically Modified siRNAs Silence Huntingtin mRNA in Primary Neurons and Mouse Brain
resolves10.1158/0008-5472.CAN-08-3886
Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
resolves10.1089/jop.2013.0148
Novel Hydrophobically Modified Asymmetric RNAi Compounds (sd-rxRNA) Demonstrate Robust Efficacy in the Eye
resolves10.1021/jm049167j
Fully 2‘-Modified Oligonucleotide Duplexes with Improved in Vitro Potency and Stability Compared to Unmodified Small Interfering RNA
resolves10.1038/mtna.2016.50
Docosahexaenoic Acid Conjugation Enhances Distribution and Safety of siRNA upon Local Administration in Mouse Brain
resolves10.1016/j.omtn.2016.12.003
Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
resolves10.1002/1878-0261.12020
Intracranial <scp>AAV</scp>‐<scp>IFN</scp>‐β gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model
resolves10.1089/nat.2015.0578
A High-Throughput Method for Direct Detection of Therapeutic Oligonucleotide-Induced Gene Silencing <i>In Vivo</i>
resolves10.1093/nar/gkv942
Guanabenz (Wytensin™) selectively enhances uptake and efficacy of hydrophobically modified siRNAs
resolves10.15252/emmm.201505495
Therapeutic potential of targeting microRNA‐10b in established intracranial glioblastoma: first steps toward the clinic
resolves10.18632/oncotarget.20193
Culture conditions defining glioblastoma cells behavior: what is the impact for novel discoveries?
resolves10.1126/science.1254257
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
resolves10.2217/fon.15.22
Molecular Targets in Glioblastoma
resolves10.1021/acs.bioconjchem.7b00226
Synthesis and Evaluation of Parenchymal Retention and Efficacy of a Metabolically Stable <i>O</i>-Phosphocholine-<i>N</i>-docosahexaenoyl-<scp>l</scp>-serine siRNA Conjugate in Mouse Brain
resolves10.1038/onc.2013.436
DRR regulates AKT activation to drive brain cancer invasion
resolves10.1093/nar/gkw236
The delivery of therapeutic oligonucleotides
resolves10.1158/1078-0432.CCR-03-0740
Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain Cancer
resolves10.1073/pnas.182272699
RNAi functions in cultured mammalian neurons
resolves10.1517/13543770802680195
Delivery of small-interfering RNA (siRNA) to the brain
resolves10.1056/NEJMoa1609243
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
resolves10.18632/oncotarget.3632
RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model
resolves10.1126/science.354.6318.1359
Antisense rescues babies from killer disease
The 1 reference without a DOI — listed, not checked
no DOI — not checkedSystemic AAV9-IFNbeta gene delivery treats highly invasive glioblastoma
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

view as graph · paper page

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1158/1535-7163.mct-17-1144"><img src="https://citestamp.com/citestamped/10.1158/1535-7163.mct-17-1144/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1158/1535-7163.mct-17-1144/badge.svg)](https://citestamp.com/citestamped/10.1158/1535-7163.mct-17-1144)